May 25, 2018
Rose
New York City-based Owkin, which uses machine learning to enhance biomedical research, has raised $7 million in Series A follow-on funds. GV, the venture arm of Alphabet formerly known as Google Ventures, was the sole investor. After Owkin picked up $11 million in January, this new raise brings the company's Series A funding to $18 million and its total funding to $20 million.
from MobiHealthNews https://ift.tt/2kpHh1B
May 25, 2018
Rose
MobiHealthNews
No comments
Related Posts:
Qualcomm Life signs deal with AlertWatch, PeriGen, and other digital health deals- Helix raises $200 million to grow genomics testing marketplace
- Novartis, Pear Therapeutics sign development deal for two digital therapeutics
- Philips to launch new version of HealthSuite with AI and analytics at HIMSS18
- PlushCare taps Thermo Fisher Scientific to offer telemedicine allergy consultations
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment